2.7 million lives estimated to have been saved by MMV-supported medicines

MMV and partners have made great strides towards contributing to the global drive towards malaria eradication as well as Sustainable Development Goal 3 to achieve good health and wellbeing for all. Since its foundation in 1999, eleven new medicines have been developed and brought forward with partners, with two more added to the portfolio post-approval (see full list below). The impact of these new antimalarials has been impressive. In total, they have saved an estimated 2.7 million lives. 

Medicines supported by MMV and partners:

→View key access milestones for individual products.

→View our products and projects page for more information on each product.